U.S. patent 6495162: Controlled release oral tablet having a unitary core. Granted to Cheng et. al. (4 total) on 2002-12-17 (filed 2001-11-01) and assigned to Andrx Pharmaceuticals, Inc.. Currently involved in at least 1 patent litigation: Takeda Pharmaceutical Company Limited et. al. v. Mylan, Inc. et. al. (Pennsylvania). See http://news.priorsmart.com for more info.
Original Title
Controlled release oral tablet having a unitary core (US patent 6495162)
U.S. patent 6495162: Controlled release oral tablet having a unitary core. Granted to Cheng et. al. (4 total) on 2002-12-17 (filed 2001-11-01) and assigned to Andrx Pharmaceuticals, Inc.. Currently involved in at least 1 patent litigation: Takeda Pharmaceutical Company Limited et. al. v. Mylan, Inc. et. al. (Pennsylvania). See http://news.priorsmart.com for more info.
U.S. patent 6495162: Controlled release oral tablet having a unitary core. Granted to Cheng et. al. (4 total) on 2002-12-17 (filed 2001-11-01) and assigned to Andrx Pharmaceuticals, Inc.. Currently involved in at least 1 patent litigation: Takeda Pharmaceutical Company Limited et. al. v. Mylan, Inc. et. al. (Pennsylvania). See http://news.priorsmart.com for more info.